What does a persistently elevated Epstein-Barr virus (EBV) viral capsid antigen (VCA) IgG with a negative VCA IgM over the past year indicate?

EBV VCA IgG positive for 12 months with negative VCA IgM

Persistently elevated EBV VCA IgG with negative VCA IgM over a year almost always indicates past EBV infection with immune memory, not active disease. 1, 2

• What this serology means

  • VCA IgG persists for life after infection; absence of VCA IgM argues strongly against recent primary infection or acute reactivation in immunocompetent patients 1, 2.
  • By itself, this pattern does not increase morbidity, mortality, or impair quality of life.

• When to consider chronic active EBV (CAEBV) or other serious EBV disease

  • Only if ALL are present: persistent/recurrent mono-like symptoms (fever, lymphadenopathy, hepatosplenomegaly), plus atypical serology with raised VCA and EA and/or increased EBV DNA in blood/tissues, and no alternative diagnosis 3.
  • CAEBV is rare, often T/NK-cell–driven, and linked to worse outcomes when accompanied by thrombocytopenia, late onset, or T-cell infection 3.
  • Elevated VCA IgG alone without symptoms or EBV DNAemia does not meet CAEBV criteria and should not prompt treatment or labeling as chronic EBV 3.

• Practical algorithm (prioritizing morbidity/mortality/QoL)

  1. Asymptomatic or only nonspecific fatigue:
     • Interpret as past EBV infection; no further EBV testing or treatment is indicated. Reassure. 1, 2
  2. Concerning features suggesting CAEBV or EBV complications:
     • Specific red flags: persistent fever, tender lymphadenopathy, hepatosplenomegaly, cytopenias, hepatitis, pneumonitis, neurologic or cardiovascular involvement 3.
     • If present, order:
       • Quantitative EBV DNA PCR (whole blood/plasma) to assess DNAemia 3.
       • EA (early antigen) IgG and EBNA-1 IgG; consider IgG avidity only if acute vs recent unclear 1, 4.
       • If organ involvement suspected, biopsy with EBER in situ hybridization to prove EBV disease in tissue (gold standard for EBV-PTLD and other EBV diseases) 5.
  3. Immunocompromised/post-transplant:
     • Follow transplant-specific DNAemia monitoring and tissue-based diagnosis for PTLD; antivirals do not treat latent EBV; use preemptive strategies per guidelines if DNAemia high-risk 5.

• Common pitfalls and how to avoid them

  • Overcalling “chronic EBV” based on VCA IgG alone—requires symptoms plus EA elevation and/or EBV DNAemia and exclusion of other causes 3.
  • Chasing low-level or isolated serologic abnormalities without clinical correlation; prioritize DNA PCR and tissue confirmation only when clinically indicated 5.
  • Misinterpreting serology panels; use EBNA-1 IgG and VCA IgM with VCA IgG for clear categorization; high-quality assays perform well, but IgM can be misleading; avidity helps only in suspected recent primary infection 6, 7, 1, 8, 4.

• Bottom line action for this case

  • If no sustained mono-like symptoms or organ involvement: no further EBV workup; document past infection; focus on alternative explanations for symptoms if any (e.g., anemia, thyroid, sleep, depression). 1, 2
  • If red flags exist: proceed with EBV DNA PCR and targeted evaluation as above; consider tissue diagnosis if organ disease suspected to impact morbidity/mortality 3, 5.